BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Aug. 7, 2002
View Archived Issues
Genaissance Cuts Back, Cites Pressure On Pharmacogenomics
Read More
Protein Named SHIP Regulates Osteoclast-Osteoblast Seesaw In Researching Paget's Disease
Read More
Quorex Adds $10.6M To Series B To Fund Antibacterials Program
Read More
Other News To Note
Read More
Quarterly Earnings Reports
Read More
FDA Panel Backs Gilead Drug For Treating Chronic Hepatitis B
BETHESDA, Md. - An FDA panel of experts unanimously recommended approval of Gilead Sciences Inc.'s once-daily tablet, adefovir dipivoxil, for chronic hepatitis B. (BioWorld Today)
Read More